| Patents for C07H 17 - Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals (11,681) |
|---|
| 05/25/2005 | CN1203083C Rhizoma anemarrhenae extract and preparation process |
| 05/24/2005 | US6897299 Process for producing erythromycin derivative |
| 05/24/2005 | CA2326076C Novel macrolides |
| 05/19/2005 | WO2005044834A1 A stabilized azithromycin composition |
| 05/19/2005 | US20050107310 Carboxylic acid glycuronides, glycosamides and glycosides of quinolones, penicillins, analogs, and uses thereof |
| 05/19/2005 | CA2544755A1 A stabilized azithromycin composition |
| 05/18/2005 | CN1616381A Process for preparing Erigeron breviscapus active component |
| 05/18/2005 | CN1202116C Avermectin derivatives |
| 05/18/2005 | CN1201741C Preventives and remedies for ischemic reflow disorder |
| 05/17/2005 | US6894034 Sebum production inhibitors |
| 05/12/2005 | WO2005042555A1 Tyrosinase activity inhibitor and ameliorant for facial blood flow |
| 05/12/2005 | WO2005042554A1 Bifunctional macrolide heterocyclic compounds and methods of making and using the same |
| 05/12/2005 | US20050101548 Bactericides |
| 05/12/2005 | US20050101547 Stabilized as hydrates; controlling water concentration |
| 05/11/2005 | EP1529053A2 Macrolide compounds endowed with antiinflammatory activity |
| 05/11/2005 | EP1529052A2 Lincomycin derivatives possessing antibacterial activity |
| 05/11/2005 | CN1613863A Extracting method for taxane compound |
| 05/11/2005 | CN1200916C Preparation method of total saponin and flavone extract in notoginseng leaf |
| 05/10/2005 | CA2222995C Ionic molecular conjugates of n-acylated derivatives of poly(2-amino-2-deoxy-d-glucose) and polypeptides |
| 05/06/2005 | WO2005039500A2 METHOD FOR THE PRODUCTION OF BIOACTIVE SUBSTANCES FROM THE NOVEL ACTINOMYCETE TAXON MAR2 (“Marinophilus”) |
| 05/06/2005 | CA2546737A1 Method for the production of bioactive substances from the novel actinomycete taxon mar2 ("marinophilus") |
| 05/06/2005 | CA2543404A1 Novel inhibitor of the formation of advanced glycation end product and aldose reductase inhibitor |
| 05/04/2005 | EP1527160A2 Production of glycosylated macrolides in e. coli |
| 05/04/2005 | EP1526860A2 Bioavailability/bioefficacy enhancing activity of cuminum cyminum and extracts and fractions thereof |
| 05/04/2005 | EP1414835B1 9a-n-[n'-(phenylsulfonyl)carbamoyl] derivatives of 9-deoxo-9-dihydro-9a-aza-9a-homoerythromycin a and of 5-o-desosaminyl-9-deoxo-9-dihydro-9a-aza-9a-homoerythronolide a |
| 05/04/2005 | EP1272500B1 Process for preparing 6-o-alkenyl-subsituted erythromycin derivatives |
| 05/04/2005 | CN1612888A Macrolides |
| 05/04/2005 | CN1199647C Application of icariin in preparation of medicine for preventing and treating sexual disfunction |
| 04/28/2005 | US20050090461 Synthesizing polyketide fusion protein comprising acyltransferase domain for use as anthelminthic, insecticide, antitumor, immunosuppressant, fungicidal and/or bactericidal agents |
| 04/28/2005 | US20050090460 9a,11-3C-bicyclic 9a-azalide derivatives |
| 04/28/2005 | US20050090459 Crystal forms of azithromycin |
| 04/28/2005 | US20050090458 Salts of avermectins substituted in the 4"-position and having pesticidal properties |
| 04/28/2005 | US20050090431 Water soluble prodrugs of hindered alcohols |
| 04/28/2005 | US20050089982 A hybrid polyketide synthase ("PKS") gene containing a first nucleic acid portion or portions encoding a domain of a first type I PKS, a second nucleic acid portion or portions encoding type I PKS domain which is heterologous to first PKS; Saccharopolyspora species or Streptomyces species as host cell |
| 04/28/2005 | US20050089884 Genes coding for ketosynthase, acyl transferase, acyl carrier protein, ketoreductase, dehydratase and enoyl reductase domains, and genes coding for modifier enzymes, such as ABC transporter, cytochrome P450 monooxygenase, ferredoxin, thioesterase, 4-amino-4-deoxychorismate (ADC) synthase or lyase |
| 04/28/2005 | CA2541425A1 Composition comprising xanthoceras sorbifolia extracts, compounds isolated from same, methods for preparing same and uses thereof |
| 04/27/2005 | EP1524966A1 Taste masked oral composition of telithromycin |
| 04/27/2005 | CN1610691A 2-O-(beta-D-glucopyranosyl)ascorbic acid, process for its production, and foods and cosmetics containing compositions comprising it |
| 04/27/2005 | CN1609114A Notoginseng leaf total flavone and its prepn and application |
| 04/27/2005 | CN1198834C Water soluble produgs of hindered alcohols or phenols |
| 04/26/2005 | US6884604 Generation of random nucleotide sugar libraries for use in the generation of coumarin and ertyhronilide derivatives; obtain nucleotide sugar, incubate with glycosyltransferase, recover glycosylated product |
| 04/21/2005 | WO2005036169A2 Fluorescent probes for ribosomes and method of use |
| 04/21/2005 | WO2005034856A2 Targeted drug-formaldehyde conjugates and methods of making and using the same |
| 04/21/2005 | WO2005034846A2 Withanamide and withanolide compositions and method of use thereof |
| 04/21/2005 | US20050085431 Treatment of hypertension |
| 04/21/2005 | US20050084548 Antiobestic and/or antidiabetic agent containing cyanidin 3-glucoside as active ingredient |
| 04/20/2005 | EP1523488A1 Novel thiophenylglycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof |
| 04/20/2005 | EP1523465A1 An hydroxytyrosol-rich composition from olive vegetation water and method of use thereof |
| 04/20/2005 | EP1523321A1 Use of ginkgo biloba extracts in order to promote muscle mass to the detriment of fatty mass |
| 04/20/2005 | CN1608075A Avermectin b1 derivatives having an aminosulfonyloxy substitutent in the 4''-position |
| 04/20/2005 | CN1197870C Process for producing erythromycin derivative and its intermediate |
| 04/19/2005 | US6881430 Food coloring substances and method for their preparation |
| 04/14/2005 | WO2005033123A1 Stable vitamin b6 derivative |
| 04/14/2005 | WO2004108746A3 11-12 bicyclic erythromycin derivatives |
| 04/14/2005 | WO2004014295A3 Tiacumicin production |
| 04/14/2005 | US20050080025 Macrolides |
| 04/14/2005 | US20050080003 Compounds with anti-inflammatory activity |
| 04/14/2005 | CA2544574A1 Stable vitamin b6 derivative |
| 04/13/2005 | EP1521765A1 Bafilomycin-like metabolite from a novel micromonospora species |
| 04/13/2005 | EP1521764A2 New compounds, compositions and methods for treatment of inflammatory diseases and conditions |
| 04/13/2005 | EP1521763A2 Novel nonsteroidal anti-inflammatory substances, compositions and methods for their use |
| 04/13/2005 | CN1196709C Troxerutin with high trihydroxy-ethyl-rutin content and method for preparing same |
| 04/13/2005 | CN1196708C Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-1-[4-(2-amin-1-yl-ethoxy)-benzyl)-1h-indol-5-ols |
| 04/12/2005 | US6878691 6-11 bicyclic ketolide derivatives |
| 04/12/2005 | CA2228670C Novel 5-o-deoaminyl 6-o-methyl erythronolide a derivatives, method for preparing same and application thereof for preparing biologically active products |
| 04/07/2005 | WO2005030785A2 Novel thioxylose compounds, preparation method thereof, pharmaceutical compositions containing same and use thereof in therapeutics |
| 04/07/2005 | WO2005030233A1 Active oxygen scavenging agent and process for producing the same |
| 04/07/2005 | WO2005030227A1 9a, 11-3C-BICYCLIC 9a-AZALIDE DERIVATIVES |
| 04/07/2005 | WO2005021566A3 Glucopyranosyloxy- pirazoles, drugs containing said compounds the use and production method thereof |
| 04/07/2005 | US20050074857 Method for producing a pyrimidine nucleoside compound and a new pyrimidine nucleoside compound |
| 04/07/2005 | DE10342292A1 New macrolide oxazolidinone derivatives useful for treating bacterial infections |
| 04/06/2005 | CN1195750C Recovery of isoflavones from soy molasses |
| 04/05/2005 | US6875576 Detection of modulators of receptor binding activity; obtain sample containing receptor, incubate with modulator, monitor adjustment of binding activity of receptor |
| 04/05/2005 | US6875422 Oral treatment/care agent |
| 03/31/2005 | WO2005028630A2 Engineered zinc finger proteins for regulation of gene expression |
| 03/31/2005 | WO2005028493A1 Antimicrobial derivatives |
| 03/31/2005 | WO2005028492A1 CRYSTALLINE COMPOUND OF 4'-DEMETHYL-4'-PHOSPHATE-2',3'-BISPENTAFLUOROPHENOXYACETYL-4',6'-ETHYLIDENE-β-D-EPIPODOPHYLLOTOXIN GLUCOSIDE EITHER IN ITS FREE FORM OR SOLVATED WITH ETHANOL |
| 03/31/2005 | WO2005027828A2 Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof |
| 03/31/2005 | WO2005027622A1 Delphinium flower color crossing method |
| 03/31/2005 | WO2004094449A8 Macrolide-conjugates with anti-inflammatory activity |
| 03/31/2005 | US20050070464 Complex of sialic acid or a sialic acid derivative in an alpha 2-3 bond, galactose-monosaccharide, N-acetylated galactosamine-monosaccharide or glucosamine-monosaccharide, galactose- or glucose-monosaccharide; immunomodulation, immunosuppression and for treating infections in humans and animals |
| 03/31/2005 | CA2539067A1 Crystalline compound of 4'-demethyl-4'-phosphate-2",3"-bispentafluorophenoxyacetyl-4",6"-ethylidene-.beta.-d-epipodophyllotoxin glucoside either in its free form or solvated with ethanol |
| 03/30/2005 | CN1194983C Process for extracting anthoxyanin from cowbeery |
| 03/29/2005 | US6872838 Derivatives of water insoluble drugs which exhibit good activity and water solubility |
| 03/29/2005 | US6872713 Plant extracts |
| 03/29/2005 | US6872707 Prevention, therapy of bacteria infections |
| 03/24/2005 | WO2005025490A2 Novel polyol macrolide antitumor-antibiotics from the novel marine actinomycete strain cnq140 |
| 03/24/2005 | WO2004108744A3 Azalides and azaketolides having antimicrobial activity |
| 03/24/2005 | US20050065101 Halogenation with a diphenylhalosulfonimide, deblocking the protected hydroxyl group; optional esterification or addition salt formation |
| 03/24/2005 | DE10339549A1 New glucopyranosyloxy-pyrazole derivatives are sodium dependent glucose cotransporter inhibitors used for treating and preventing metabolic disorders, particularly diabetes |
| 03/23/2005 | CN1597678A Extraction method of hawthorn leaf total flarone |
| 03/23/2005 | CN1193751C Therpauetic agent of osteoporisis comprising active ingredient of quercetin derivatives |
| 03/22/2005 | CA2326930C Preparation of non-crystalline and crystalline dihydrate forms of azithromycin |
| 03/17/2005 | US20050059727 Withanamide and withanolide compositions and method of use thereof |
| 03/16/2005 | EP1513857A1 Process for preparing high purity azithromycin |
| 03/16/2005 | EP1513856A1 3-descladinosyl-6-o-carbamoyl and 6-o-carbonoyl macrolide antibacterial agents |
| 03/16/2005 | EP1420779A4 Process for isolating phenolic compounds |
| 03/16/2005 | CN1594346A Flavanone glycoside and its preparation and use |
| 03/16/2005 | CN1594345A 3-hydroxy-chromogen ketoside and its preparation and use |
| 03/16/2005 | CN1594344A Process for separating high pure neohesperidin from fruit of citron or trifoliate orange |